Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.
van der Leest RJ, de Vries E, Bulliard JL, Paoli J, Peris K, Stratigos AJ, Trakatelli M, Maselis TJ, Situm M, Pallouras AC, Hercogova J, Zafirovik Z, Reusch M, Olah J, Bylaite M, Dittmar HC, Scerri L, Correia O, Medenica L, Bartenjev I, Guillen C, Cozzio A, Bogomolets OV, del Marmol V. van der Leest RJ, et al. Among authors: reusch m. J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1455-65. doi: 10.1111/j.1468-3083.2011.04228.x. Epub 2011 Sep 23. J Eur Acad Dermatol Venereol. 2011. PMID: 21951235
Crusted scabies of the vulva.
Bakos L, Reusch MC, D'Elia P, Aquino V, Bakos RM. Bakos L, et al. Among authors: reusch mc. J Eur Acad Dermatol Venereol. 2007 May;21(5):682-4. doi: 10.1111/j.1468-3083.2006.01978.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17447985 No abstract available.
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.
Zarbock A, Larsson TE, Noiseux N, Mazer CD, Böhm J, Laflamme M, Matschke K, Burkert J, de Varennes B, Myjavec A, Böning A, Koyner JL, Engelman D, Reusch M, Thielmann M; AKITA investigators. Zarbock A, et al. Among authors: reusch m. EClinicalMedicine. 2024 Sep 16;76:102830. doi: 10.1016/j.eclinm.2024.102830. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39318788 Free PMC article.
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.
Barratt J, Dellanna F, Portoles J, Choukroun G, De Nicola L, Young J, Dimković N, Reusch M. Barratt J, et al. Among authors: reusch m. Adv Ther. 2023 Apr;40(4):1546-1559. doi: 10.1007/s12325-023-02433-0. Epub 2023 Feb 7. Adv Ther. 2023. PMID: 36749544 Free PMC article. Clinical Trial.
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
Csiky B, Schömig M, Esposito C, Barratt J, Reusch M, Valluri U, Sulowicz W. Csiky B, et al. Among authors: reusch m. Adv Ther. 2021 Oct;38(10):5361-5380. doi: 10.1007/s12325-021-01904-6. Epub 2021 Sep 19. Adv Ther. 2021. PMID: 34537926 Free PMC article. Clinical Trial.
88 results